Evaluating the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial.

Saghar Barati,Hossein Amini,Zargham Hossein Ahmadi,Alireza Dastan,Babak Sharif Kashani,Raha Eskandari,Farzaneh Dastan

Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology（2023）

引用 5|浏览10

暂无评分

摘要

Rivaroxaban may be as effective as warfarin in treating CTEPH patients after endarterectomy in the short term and can be used as an anticoagulant in these patients. However, studies with long-term follow-ups are needed to consolidate the strategy of treating these patients with rivaroxaban.

查看译文

关键词

Chronic thromboembolic pulmonary hypertension,Cirurgia,Endarterectomia,Endarterectomy,Hipertensão pulmonar tromboembólica crónica,Rivaroxaban,Rivaroxabano,Surgery,Varfarina,Warfarin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要